Skip to main content

Table 3 EQ-5D-5L health index and EQ-VAS values for whole study population (n = 366) at the baseline, end of treatment, first, second, third, fourth and fifth follow up

From: Patient reported outcomes based on EQ-5D-5L questionnaires in head and neck cancer patients: a real-world study

All n = 366

Health utility index

All n = 366

Questionnaries n = 565

Mean

SD

SE of diff

Mean diff

0.5 SD

p-valuea

Baseline

221

0,804

0,208

  

0,104

 

RT end

114

0,830

0,162

0,023

−0,026

0,081

0,927

1 FU

89

0,812

0,205

0,028

0,018

0,103

0,802

2 FU

32

0,769

0,224

0,041

0,042

0,112

0,302

3 FU

54

0,834

0,217

0,044

−0,064

0,109

0,087

4 FU

22

0,840

0,192

0,050

−0,006

0,100

0,555

5 FU

33

0,877

0,127

0,054

-0,037

0,064

0,058

All n = 366

VAS

All n = 366

Questionnaries n = 565

Mean

SD

SE of diff

Mean diff

0.5 SD

p-valuea

Baseline

221

62,06

23,94

  

11,97

 

RT end

114

66,73

82,20

4,87

−4,66

41,10

0,266

1 FU

89

63,30

22,74

5,29

−1,24

11,37

0,711

2 FU

32

65,48

23,39

8,07

−3,42

11,70

0,526

3 FU

54

77,30

19,92

6,39

−15,23

9,96

< 0,0001

4 FU

22

67,27

19,07

9,41

−5,21

9,54

0,416

5 FU

33

73,64

15,48

7,85

−11,57

7,74

0,009

  1. Abbreviation: aMann-Whitney U test for comparison of health utility values at the end of radiation and follow up each to baseline, RT Radiotherapy, SD Standard deviation, SE of diff Standard error of difference, VAS Visual analog scale